Synthesis, physico-chemical and biological characterization of a paclitaxel macromolecular prodrug.

作者: G. Cavallaro , M. Licciardi , P. Caliceti , S. Salmaso , G. Giammona

DOI: 10.1016/J.EJPB.2004.02.012

关键词:

摘要: Abstract Paclitaxel was attached to poly(hydroxyethylaspartamide) via a succinic spacer arm by two-step protocol: (1) synthesis of 2′- O -succinyl-paclitaxel; (2) PHEA-2′- -succinyl-paclitaxel. The -succinyl-paclitaxel derivative and the macromolecular conjugate were characterized UV, IR, NMR mass spectrometry analysis. reaction yields over 95% purity products 98%. release degradation from occurred at faster rate pH 5.5 than 7.4. After 30 h incubation 7.4 released free paclitaxel about 40 20%, respectively. In plasma both drug found occur higher in buffer suggesting that an enzymatic mechanism could be involved. negligible very slow plasma. Investigation carried out using murine myeloid cell line showed polymeric prodrug maintains partial pharmacological activity paclitaxel. DL50 (over ng/ml) as compared (about 1 correlated release. Finally pharmacokinetic study intravenous inoculation mice demonstrated polymer conjugation modify dramatically vivo fate drug. disappeared bloodstream much more quickly naked polymer. Massive accumulation bioconjugate liver (80% dose) persist throughout week.

参考文章(31)
Matthew Suffness, None, Taxol®: science and applications. (1995). ,(1995)
Hayat Alkan‐Onyuksel, Suganthi Ramakrishnan, Hee‐Byung Chai, John M. Pezzuto, A Mixed Micellar Formulation Suitable for the Parenteral Administration of Taxol Pharmaceutical Research. ,vol. 11, pp. 206- 212 ,(1994) , 10.1023/A:1018943021705
Adams Jd, Wilson Jw, Finley R, Flora Kp, Goldspiel Br, Arbuck Sg, Taxol: a history of pharmaceutical development and current pharmaceutical concerns. Journal of The National Cancer Institute Monographs. pp. 141- 147 ,(1993)
Wanda N Waugh, Lawrence A Trissel, Valentino J Stella, None, Stability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers. American Journal of Health-system Pharmacy. ,vol. 48, pp. 1520- 1524 ,(1991) , 10.1093/AJHP/48.7.1520
Martin C Garnett, Targeted drug conjugates: principles and progress Advanced Drug Delivery Reviews. ,vol. 53, pp. 171- 216 ,(2001) , 10.1016/S0169-409X(01)00227-7
Paolo Caliceti, Oddone Schiavon, Francesco M. Veronese, Biopharmaceutical properties of uricase conjugated to neutral and amphiphilic polymers. Bioconjugate Chemistry. ,vol. 10, pp. 638- 646 ,(1999) , 10.1021/BC980155K
Monroe E. Wall, Mansukh C. Wani, Camptothecin and taxol: from discovery to clinic Journal of Ethnopharmacology. ,vol. 51, pp. 239- 254 ,(1996) , 10.1016/0378-8741(95)01367-9
Abraham E Mathew, Magdalena R Mejillano, Jyoti P Nath, Richard H Himes, Valentino J Stella, None, Synthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor activity Journal of Medicinal Chemistry. ,vol. 35, pp. 145- 151 ,(1992) , 10.1021/JM00079A019